Claire Bombardier

Claire Bombardier

Senior Scientist
Toronto General Research Institute
Mt. Sinai Hospital

Claire Bombardier, MD, FRCP(C),
Master of the American College of Rheumatology (ACR)
Distinguished Clinician-Investigator of the ACR

Dr. Bombardier is currently:

    • a Rheumatologist at Mt Sinai Hospital
    • a Senior Scientist at Toronto General Research Institute
    • a Professor of Medicine at the University of Toronto

Dr. Bombardier was the founding director of the clinical epidemiology program at the University of Toronto and a cofounder of the Institute for Work & Health (an independent, not-for-profit research organization). She was also the co-scientific director of CAN (Canadian Arthritis Network) a national center of excellence, also a not-for-profit organization that supports integrated, trans-disciplinary research and development and is the past Director of the University of Toronto Rheumatology Program.

She has led the development of guidelines for the safe pharmacologic treatment of rheumatoid arthritis patients in Canada and abroad. For the last 10 years, her research has focussed on real-world evidence of safety and effectiveness of new drugs. To this effect she created “The Ontario Best Practice Research Initiative (OBRI –” which is a Province wide registry of Ontario patients with rheumatoid arthritis with clinical data linked to ICES (Institute for Clinical Evaluative Sciences) which is the universal repository of billings coverage in Ontario.
Her commitment to excellence in rheumatology is recognized, and as a Principal Investigator brings research expertise and visionary leadership to the OBRI team.

Dr. Bombardier has received many noteworthy awards and distinctions, including the ACR Distinguished Clinician Scholar Award (11/2016) and the prestigious American College of Rheumatology Master Designation Award (MACR) in 2013 for outstanding contributions in the field of rheumatology. In March of this year (2019), she was named the inaugural recipient of a lifetime achievement award and honouree by The Arthritis Society (TAS) at their Special Gala 70th Anniversary event.

Dr. Bombardier has published more than 366 scholarly articles and is the recipient of numerous competitive grants. Professional interests include the improvement of clinical effectiveness, optimum use of technology and drugs, performance measurement/program evaluation, with a focus on real word data.